The prognostic significance of DNA cytophotometry and proliferation index (Ki-67) in giant cell tumors of bone

被引:34
|
作者
Antal, I [1 ]
Sápi, Z [1 ]
Szendröi, M [1 ]
机构
[1] Semmelweis Univ Med, Sch Med, Dept Orthoped, H-1113 Budapest, Hungary
关键词
D O I
10.1007/s002640050381
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
We studied DNA ploidy by smear cytophotometry and proliferation activity by Ki-67 MIB immunohistochemistry in 69 primary and recurrent giant cell tumors (GCT) from 50 randomly selected patients. The obtained results were evaluated with comparisons made to the available clinical data. From the 46 primary tumors 63% showed diploidy and 37% aneuploidy. A significantly (P = 0.026) higher recurrence rate (64%) was observed in aneuploid than in diploid tumors (31%). In the course of the recurrences, both the ratio of aneuploid tumors as well as the proliferation index of the tumors increased, though the degree of the latter was non-significant. Aneuploidy did not mean an unambiguous tendency towards malignant transformation; however, a close follow-up of recurrent aneuploid tumors, and wide excision of the recurrence instead of intralesional curettage are the recommended procedures. The DNA cytophotometry and proliferation index of GCTs - as compared to other histologic examinations - are of prognostic value in the evaluation of the recurrence potential of the GCTs.
引用
收藏
页码:315 / 319
页数:5
相关论文
共 50 条
  • [21] Prognostic value of Ki-67 index in primary intracranial tumors of infants
    Alican Tahta
    Nejat Akalan
    Child's Nervous System, 2023, 39 : 369 - 377
  • [22] Ki-67 (clone MIB-1) proliferation index in recurrent glial neoplasms: No prognostic significance
    Litofsky, NS
    Mix, TCH
    Baker, SP
    Recht, LD
    Smith, TW
    SURGICAL NEUROLOGY, 1998, 50 (06): : 579 - 585
  • [23] Ki-67 immuno-histochemistry index in stage III giant cell tumor of the bone
    Faisham W Ismail
    Aminudin M Shamsudin
    Zulmi Wan
    Salzihan M Daud
    Mutum S Samarendra
    Journal of Experimental & Clinical Cancer Research, 29
  • [24] PROGNOSTIC ROLE OF KI-67 INDEX AND MITOTIC INDEX IN NEUROENDOCRINE TUMORS OF HETEROGENOUS ORIGIN
    Triveni, B.
    Kumar, Sandeep L.
    Mallikarjun, S. Sai
    Lakshmi, Sri
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2014, 3 (67): : 14438 - 14444
  • [25] DNA CONTENT AND THE PROLIFERATION MARKER KI-67 AS PROGNOSTIC INDICATORS IN RENAL-CELL CARCINOMA
    PAPADOPOULOS, I
    WEICHERTJACOBSEN, K
    SPRENGER, E
    WACKER, HH
    UROLOGIA INTERNATIONALIS, 1994, 53 (04) : 181 - 185
  • [26] Heterogeneity in the Ki-67 Index of Neuroendocrine Tumors
    Miller, H.
    Flora, R.
    Drymousis, P.
    Wasan, H.
    Goldin, R.
    Schmid, K. W.
    Kidd, M.
    Modlin, I. M.
    Frilling, A.
    NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 249 - 249
  • [27] KI-67 INDEX VARIABILITY IN NEUROENDOCRINE TUMORS
    Craig, J.
    Cheung, M.
    Law, C.
    Singh, S.
    ANNALS OF ONCOLOGY, 2012, 23 : 377 - 378
  • [28] Ki-67 proliferation index - Correlation with prognostic parameters and outcome in multiple myeloma
    Alexandrakis, MG
    Passam, FH
    Kyriakou, DS
    Dambaki, K
    Niniraki, M
    Stathopoulos, E
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (01): : 8 - 13
  • [29] Ki-67 Index Variability in Neuroendocrine Tumors
    Craig, Jeffrey
    Singh, Simron
    Law, Calvin
    Cheung, Matthew
    PANCREAS, 2013, 42 (02) : 372 - 372
  • [30] Cut-point for Ki-67 proliferation index as a prognostic marker for glioblastoma
    Wong, Eugene
    Nahar, Najmun
    Hau, Eric
    Varikatt, Winny
    Gebski, Val
    Ng, Thomas
    Jayamohan, Jayasingham
    Sundaresan, Puma
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 (01) : 5 - 9